Literature DB >> 16988009

Human immunodeficiency virus persistence and production in T-cell development.

Kevin B Gurney1, Christel H Uittenbogaart.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication depends on CD4 and coreceptor expression as well as host factors associated with the activation state of the cell. To determine the impact of the activation stage of thymocytes on the HIV-1 life cycle, we investigated R5 and X4 HIV-1 entry, reverse transcription, and expression in discrete thymocyte subsets at different stages of T-cell development. Early after infection, preferential entry and replication of R5 HIV-1 were predominantly detected in mature CD3(+/hi) CD27(+) thymocytes. Thus, R5 HIV-1 targets the stage of development where thymocytes acquire functional responsiveness, which has important implications for HIV pathogenesis. In contrast, X4 HIV-1 expression and replication were primarily found in immature CD3(-/+/low) CD27(-) CD69(-) thymocytes. HIV-1 proviral burden and virus expression in thymocyte subsets correlated with the expression of the highest levels of the respective coreceptor. R5 and X4 HIV-1 entered and completed reverse transcription in all subsets tested, indicating that the activation state of thymocytes and coreceptor expression are sufficient to support full reverse transcription throughout development. Although R5 HIV-1 is expressed mainly in mature CD3(+/hi) CD27(+) thymocytes, 5.3% of HIV-1-infected immature thymocytes express R5 HIV-1, indicating that potentially latent viral DNA can be established early in T-cell development.

Entities:  

Mesh:

Year:  2006        PMID: 16988009      PMCID: PMC1656539          DOI: 10.1128/CVI.00184-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  51 in total

1.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

Authors:  M Baba; O Nishimura; N Kanzaki; M Okamoto; H Sawada; Y Iizawa; M Shiraishi; Y Aramaki; K Okonogi; Y Ogawa; K Meguro; M Fujino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication.

Authors:  Y Bakri; C Schiffer; V Zennou; P Charneau; E Kahn; A Benjouad; J C Gluckman; B Canque
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.

Authors:  E Vicenzi; P P Bordignon; P Biswas; A Brambilla; C Bovolenta; M Cota; F Sinigaglia; G Poli
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

Authors:  S Fais; C Lapenta; S M Santini; M Spada; S Parlato; M Logozzi; P Rizza; F Belardelli
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts.

Authors:  Raphaël Ho Tsong Fang; Emmanuel Khatissian; Valérie Monceaux; Marie-Christine Cumont; Stéphanie Beq; Jean-Claude Ameisen; Anne-Marie Aubertin; Nicole Israël; Jérôme Estaquier; Bruno Hurtrel
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

6.  Loss of SDF-1 receptor expression during positive selection in the thymus.

Authors:  G Suzuki; Y Nakata; Y Dan; A Uzawa; K Nakagawa; T Saito; K Mita; T Shirasawa
Journal:  Int Immunol       Date:  1998-08       Impact factor: 4.823

7.  Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level.

Authors:  L Pedroza-Martins; K B Gurney; B E Torbett; C H Uittenbogaart
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.

Authors:  R D Berkowitz; S Alexander; C Bare; V Linquist-Stepps; M Bogan; M E Moreno; L Gibson; E D Wieder; J Kosek; C A Stoddart; J M McCune
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.

Authors:  R D Berkowitz; K P Beckerman; T J Schall; J M McCune
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level.

Authors:  H Schmidtmayerova; M Alfano; G Nuovo; M Bukrinsky
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

View more
  8 in total

1.  CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus.

Authors:  Marc Douaisi; Rachel S Resop; Maho Nagasawa; Joshua Craft; Beth D Jamieson; Bianca Blom; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

2.  Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery.

Authors:  Rachel S Resop; Marc Douaisi; Joshua Craft; Loes C M Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  J Allergy Clin Immunol       Date:  2016-04-04       Impact factor: 10.793

3.  Histoarchitectural Deterioration of Lymphoid Tissues in HIV-1 Infection and in Aging.

Authors:  Robert L Furler; Kevin L Newcombe; Perla M Del Rio Estrada; Gustavo Reyes-Terán; Christel H Uittenbogaart; Douglas F Nixon
Journal:  AIDS Res Hum Retroviruses       Date:  2019-10-07       Impact factor: 2.205

4.  A Novel HIV-1 Nef Mutation in a Primary Pediatric Isolate Impairs MHC-Class I Downregulation and Cytopathicity.

Authors:  Ayub Ali; Robert L Furler; Livia Pedroza-Martins; Arnaud D Colantonio; Deborah Anisman-Posner; Yvonne Bryson; Otto O Yang; Christel H Uittenbogaart
Journal:  AIDS Res Hum Retroviruses       Date:  2019-11-04       Impact factor: 2.205

5.  Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection.

Authors:  Dong Sung An; Betty Poon; Raphael Ho Tsong Fang; Kees Weijer; Bianca Blom; Hergen Spits; Irvin S Y Chen; Christel H Uittenbogaart
Journal:  Clin Vaccine Immunol       Date:  2007-02-21

6.  Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes.

Authors:  Helena Nunes-Cabaço; Paula Matoso; Russell B Foxall; Rita Tendeiro; Ana R Pires; Tânia Carvalho; Ana I Pinheiro; Rui S Soares; Ana E Sousa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Human T-Cell Development and Thymic Egress: An Infectious Disease Perspective.

Authors:  Rachel S Resop; Christel H Uittenbogaart
Journal:  For Immunopathol Dis Therap       Date:  2015

8.  IFN-α is constitutively expressed in the human thymus, but not in peripheral lymphoid organs.

Authors:  Arnaud D Colantonio; Marta Epeldegui; Maria Jesiak; Loes Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.